SCHEMBL13545985

SCHEMBL13545985

N#Cc1c(C2CCOC2)cc(-c2cccs2)nc1NCc1ccc(C(=O)O)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE5A O76074 1/20 0.46
▸ PDE1A P54750 1/20 0.46
▸ PDE1B Q01064 1/20 0.46
▸ PDE1C Q14123 1/20 0.46
▸ HPGDS O60760 2/20 0.41
▸ KMT2A Q03164 6/20 0.37
▸ KDM4E B2RXH2 9/20 0.37
▸ ALDH1A1 P00352 9/20 0.37
▸ HPGD P15428 8/20 0.37
▸ RXFP1 Q9HBX9 1/20 0.37
▸ ACMSD Q8TDX5 1/20 0.37
▸ GAA P10253 5/20 0.36
▸ MAPT P10636 4/20 0.36
▸ TDP1 Q9NUW8 1/20 0.36
▸ CYP1A2 P05177 1/20 0.36
▸ CYP3A4 P08684 1/20 0.36
▸ CYP2D6 P10635 1/20 0.36
▸ CYP2C9 P11712 1/20 0.36
▸ CYP2C19 P33261 1/20 0.36
▸ HIF1A Q16665 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3580550 0.85 PDE5A (0.45) PDE5APDE1APDE1BPDE1CHPGDS
SCHEMBL13545983 0.82 PDE5A (0.44) PDE5APDE1APDE1BPDE1CHPGDS
SCHEMBL13545988 0.81 PDE5A (0.46) PDE5APDE1APDE1BPDE1CHPGDS
SCHEMBL3589518 0.78 ADORA2A (0.39) PDE5APDE1APDE1BPDE1CKMT2A
SCHEMBL3594245 0.77 PDE5A (0.47) PDE5APDE1APDE1BPDE1CHPGDS
SCHEMBL13545982 0.75 PDE5A (0.46) PDE5APDE1APDE1BPDE1CHPGDS
SCHEMBL13545986 0.73 ALDH1A1 (0.47) PDE5APDE1APDE1BPDE1CHPGDS
SCHEMBL13545981 0.70 PDE5A (0.47) PDE5APDE1APDE1BPDE1CHPGDS
SCHEMBL3588911 0.69 ADORA2A (0.53) PDE5APDE1APDE1BPDE1CKMT2A
SCHEMBL3599988 0.69 ALDH1A1 (0.43) PDE5APDE1APDE1BPDE1CKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100009973-A1 Integrase Inhibitors 3 AVEXA LIMITED (AU) 2010-01-14 — — US disclosed
US-20100009973-A1 Integrase Inhibitors 3 AVEXA LIMITED (AU) 2010-01-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100009973-A1 Integrase Inhibitors 3 TYMP, IMPDH1, IMPDH2 PDE5A 531/4885PDE1A 2156/4885PDE1B 2475/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback